{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T05:32:25Z","timestamp":1783143145805,"version":"3.54.6"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T00:00:00Z","timestamp":1474588800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1038\/npp.2016.213","type":"journal-article","created":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T11:02:52Z","timestamp":1474628572000},"page":"649-660","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Pharmacokinetic Profiles and Pharmacodynamic Effects for Methylone and Its Metabolites in Rats"],"prefix":"10.1038","volume":"42","author":[{"given":"Joshua S","family":"Elmore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ora","family":"Dillon-Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S","family":"Partilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla N","family":"Ellefsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Concheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenner C","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn A","family":"Huestis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,23]]},"reference":[{"key":"BFnpp2016213_CR1","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00414-015-1212-4","volume":"130","author":"L Barrios","year":"2015","unstructured":"Barrios L, Grison-Hernando H, Boels D, Bouquie R, Monteil-Ganiere C, Clement R (2015). Death following ingestion of methylone. Int J Legal Med 130: 381\u2013385.","journal-title":"Int J Legal Med"},{"key":"BFnpp2016213_CR2","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/npp.2011.304","volume":"37","author":"MH Baumann","year":"2012","unstructured":"Baumann MH, Ayestas MA Jr ., Partilla JS, Sink JR, Shulgin AT, Daley PF et al (2012). The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology 37: 1192\u20131203.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016213_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2012.11.020","volume":"698","author":"MH Baumann","year":"2013","unstructured":"Baumann MH, Partilla JS, Lehner KR (2013). Psychoactive \u2018bath salts\u2019: not so soothing. Eur J Pharmacol 698: 1\u20135.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp2016213_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/syn.890140107","volume":"14","author":"MH Baumann","year":"1993","unstructured":"Baumann MH, Raley TJ, Partilla JS, Rothman RB (1993). Biosynthesis of dopamine and serotonin in the rat brain after repeated cocaine injections: a microdissection mapping study. Synapse 14: 40\u201350.","journal-title":"Synapse"},{"key":"BFnpp2016213_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00213-006-0322-6","volume":"189","author":"MH Baumann","year":"2007","unstructured":"Baumann MH, Wang X, Rothman RB (2007). 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings. Psychopharmacology 189: 407\u2013424.","journal-title":"Psychopharmacology"},{"key":"BFnpp2016213_CR6","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1124\/dmd.109.028506","volume":"37","author":"MH Baumann","year":"2009","unstructured":"Baumann MH, Zolkowska D, Kim I, Scheidweiler KB, Rothman RB, Huestis MA (2009). Effects of dose and route of administration on pharmacokinetics of (+ or -)-3,4-methylenedioxymethamphetamine in the rat. Drug Metab Dispos 37: 2163\u20132170.","journal-title":"Drug Metab Dispos"},{"key":"BFnpp2016213_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/PAF.0b013e31827ab5da","volume":"34","author":"PN Carbone","year":"2013","unstructured":"Carbone PN, Carbone DL, Carstairs SD, Luzi SA (2013). Sudden cardiac death associated with methylone use. Am J Forensic Med Pathol 34: 26\u201328.","journal-title":"Am J Forensic Med Pathol"},{"key":"BFnpp2016213_CR8","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/jat\/bks046","volume":"36","author":"BM Cawrse","year":"2012","unstructured":"Cawrse BM, Levine B, Jufer RA, Fowler DR, Vorce SP, Dickson AJ et al (2012). Distribution of methylone in four postmortem cases. J Anal Toxicol 36: 434\u2013439.","journal-title":"J Anal Toxicol"},{"key":"BFnpp2016213_CR9","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/0006-2952(95)02397-6","volume":"51","author":"T Chu","year":"1996","unstructured":"Chu T, Kumagai Y, DiStefano EW, Cho AK (1996). Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion. Biochem Pharmacol 51: 789\u2013796.","journal-title":"Biochem Pharmacol"},{"key":"BFnpp2016213_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1124\/dmd.113.053678","volume":"42","author":"M Concheiro","year":"2014","unstructured":"Concheiro M, Baumann MH, Scheidweiler KB, Rothman RB, Marrone GF, Huestis MA (2014). Nonlinear pharmacokinetics of (+\/-)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the rat. Drug Metab Dispos 42: 119\u2013125.","journal-title":"Drug Metab Dispos"},{"key":"BFnpp2016213_CR11","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S0091-3057(97)00323-7","volume":"58","author":"TA Dal Cason","year":"1997","unstructured":"Dal Cason TA, Young R, Glennon RA (1997). Cathinone: an investigation of several N-alkyl and methylenedioxy-substituted analogs. Pharmacol Biochem Behav 58: 1109\u20131116.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp2016213_CR12","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.tips.2004.08.001","volume":"25","author":"R de la Torre","year":"2004","unstructured":"de la Torre R, Farre M (2004). Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans. Trends Pharmacol Sci 25: 505\u2013508.","journal-title":"Trends Pharmacol Sci"},{"key":"BFnpp2016213_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1046\/j.1365-2125.2000.00121.x","volume":"49","author":"R de la Torre","year":"2000","unstructured":"de la Torre R, Farre M, Ortuno J, Mas M, Brenneisen R, Roset PN et al (2000). Non-linear pharmacokinetics of MDMA ('ecstasy') in humans. Br J Clin Pharmacol 49: 104\u2013109.","journal-title":"Br J Clin Pharmacol"},{"key":"BFnpp2016213_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00204-014-1412-6","volume":"90","author":"J Dinger","year":"2016","unstructured":"Dinger J, Meyer MR, Maurer HH (2016). In vitro cytochrome P450 inhibition potential of methylenedioxy-derived designer drugs studied with a two-cocktail approach. Arch Toxicol 90: 305\u2013318.","journal-title":"Arch Toxicol"},{"key":"BFnpp2016213_CR15","first-page":"65371","volume":"76","author":"Drug Enforcement Administration DoJ","year":"2011","unstructured":"Drug Enforcement Administration DoJ (2011). Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order. Fed Regist 76: 65371\u201365375.","journal-title":"Fed Regist"},{"key":"BFnpp2016213_CR16","first-page":"664","volume":"78","author":"Drug Enforcement Administration DoJ","year":"2013","unstructured":"Drug Enforcement Administration DoJ (2013). Establishment of drug codes for 26 substances. Final rule. Fed Regist 78: 664\u2013666.","journal-title":"Fed Regist"},{"key":"BFnpp2016213_CR17","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s11419-015-0263-z","volume":"33","author":"K Ellefsen","year":"2015","unstructured":"Ellefsen K, Concheiro M, Suzuki M, Rice K, Elmore J, Baumann M et al (2015). Quantification of methylone and metabolites in rat and human plasma by liquid chromatography-tandem mass spectrometry. Forensic Toxicol 33: 202\u2013212.","journal-title":"Forensic Toxicol"},{"key":"BFnpp2016213_CR18","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.bcp.2013.04.004","volume":"85","author":"AJ Eshleman","year":"2013","unstructured":"Eshleman AJ, Wolfrum KM, Hatfield MG, Johnson RA, Murphy KV, Janowsky A (2013). Substituted methcathinones differ in transporter and receptor interactions. Biochem Pharmacol 85: 1803\u20131815.","journal-title":"Biochem Pharmacol"},{"key":"BFnpp2016213_CR19","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/B978-0-12-420118-7.00015-9","volume":"69","author":"RA Glennon","year":"2014","unstructured":"Glennon RA (2014). Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention. Adv Pharmacol 69: 581\u2013620.","journal-title":"Adv Pharmacol"},{"key":"BFnpp2016213_CR20","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1021\/acs.chemrestox.6b00030","volume":"29","author":"GG Grecco","year":"2016","unstructured":"Grecco GG, Sprague JE (2016). Impact of functional group modifications on designer phenethylamine induced hyperthermia. Chem Res Toxicol 29: 871\u2013878.","journal-title":"Chem Res Toxicol"},{"key":"BFnpp2016213_CR21","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1124\/dmd.104.001180","volume":"32","author":"A Heydari","year":"2004","unstructured":"Heydari A, Yeo KR, Lennard MS, Ellis SW, Tucker GT, Rostami-Hodjegan A (2004). Mechanism-based inactivation of CYP2D6 by methylenedioxymethamphetamine. Drug Metab Dispos 32: 1213\u20131217.","journal-title":"Drug Metab Dispos"},{"key":"BFnpp2016213_CR22","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0022-3565(25)22646-5","volume":"245","author":"PW Kalivas","year":"1988","unstructured":"Kalivas PW, Duffy P, DuMars LA, Skinner C (1988). Behavioral and neurochemical effects of acute and daily cocaine administration in rats. J Pharmacol Exp Ther 245: 485\u2013492.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2016213_CR23","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1080\/00498250600780191","volume":"36","author":"HT Kamata","year":"2006","unstructured":"Kamata HT, Shima N, Zaitsu K, Kamata T, Miki A, Nishikawa M et al (2006). Metabolism of the recently encountered designer drug, methylone, in humans and rats. Xenobiotica 36: 709\u2013723.","journal-title":"Xenobiotica"},{"key":"BFnpp2016213_CR24","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/S0091-3057(97)00527-3","volume":"59","author":"A Kankaanpaa","year":"1998","unstructured":"Kankaanpaa A, Meririnne E, Lillsunde P, Seppala T (1998). The acute effects of amphetamine derivatives on extracellular serotonin and dopamine levels in rat nucleus accumbens. Pharmacol Biochem Behav 59: 1003\u20131009.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp2016213_CR25","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/npp.2014.191","volume":"40","author":"EA Kiyatkin","year":"2015","unstructured":"Kiyatkin EA, Kim AH, Wakabayashi KT, Baumann MH, Shaham Y (2015). Effects of social interaction and warm ambient temperature on brain hyperthermia induced by the designer drugs methylone and MDPV. Neuropsychopharmacology 40: 436\u2013445.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016213_CR26","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/jat\/bku073","volume":"38","author":"JL Knoy","year":"2014","unstructured":"Knoy JL, Peterson BL, Couper FJ (2014). Suspected impaired driving case involving alpha-pyrrolidinovalerophenone, methylone and ethylone. J Anal Toxicol 38: 615\u2013617.","journal-title":"J Anal Toxicol"},{"key":"BFnpp2016213_CR27","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/FTD.0b013e3181684fa0","volume":"30","author":"EA Kolbrich","year":"2008","unstructured":"Kolbrich EA, Goodwin RS, Gorelick DA, Hayes RJ, Stein EA, Huestis MA (2008). Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults. Ther Drug Monit 30: 320\u2013332.","journal-title":"Ther Drug Monit"},{"key":"BFnpp2016213_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1556\/OH.2012.29310","volume":"153","author":"K Kovacs","year":"2012","unstructured":"Kovacs K, Toth AR, Kereszty EM (2012). [A new designer drug: methylone related death]. Orvosi Hetilap 153: 271\u2013276.","journal-title":"Orvosi Hetilap"},{"key":"BFnpp2016213_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.pnpbp.2013.04.007","volume":"45","author":"R Lopez-Arnau","year":"2013","unstructured":"Lopez-Arnau R, Martinez-Clemente J, Carbo M, Pubill D, Escubedo E, Camarasa J (2013). An integrated pharmacokinetic and pharmacodynamic study of a new drug of abuse, methylone, a synthetic cathinone sold as \u2018bath salts\u2019. Prog Neuropsychopharmacol Biol Psychiatry 45: 64\u201372.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFnpp2016213_CR30","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1177\/0269881114548439","volume":"28","author":"R Lopez-Arnau","year":"2014","unstructured":"Lopez-Arnau R, Martinez-Clemente J, Pubill D, Escubedo E, Camarasa J (2014). Serotonergic impairment and memory deficits in adolescent rats after binge exposure of methylone. J Psychopharmacol 28: 1053\u20131063.","journal-title":"J Psychopharmacol"},{"key":"BFnpp2016213_CR31","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.forsciint.2013.06.005","volume":"231","author":"IM McIntyre","year":"2013","unstructured":"McIntyre IM, Hamm CE, Aldridge L, Nelson CL (2013). Acute methylone intoxication in an accidental drowning\u2014a case report. Forensic Sci Int 231: e1\u2013e3.","journal-title":"Forensic Sci Int"},{"key":"BFnpp2016213_CR32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/0091-3057(91)90005-M","volume":"38","author":"DJ McKenna","year":"1991","unstructured":"McKenna DJ, Guan XM, Shulgin AT (1991). 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine. Pharmacol Biochem Behav 38: 505\u2013512.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp2016213_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0014-2999(91)90664-C","volume":"200","author":"JF Nash","year":"1991","unstructured":"Nash JF, Nichols DE (1991). Microdialysis studies on 3,4-methylenedioxyamphetamine and structurally related analogues. Eur J Pharmacol 200: 53\u201358.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp2016213_CR34","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1124\/dmd.112.050880","volume":"41","author":"AJ Pedersen","year":"2013","unstructured":"Pedersen AJ, Petersen TH, Linnet K (2013). In vitro metabolism and pharmacokinetic studies on methylone. Drug Metab Dispos 41: 1247\u20131255.","journal-title":"Drug Metab Dispos"},{"key":"BFnpp2016213_CR35","first-page":"1195","volume":"63","author":"A Ridpath","year":"2014","unstructured":"Ridpath A, Driver CR, Nolan ML, Karpati A, Kass D, Paone D et al (2014). Illnesses and deaths among persons attending an electronic dance-music festival - New York City, 2013. MMWR Morb Mortal Wkly Rep 63: 1195\u20131198.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"BFnpp2016213_CR36","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3","volume":"39","author":"RB Rothman","year":"2001","unstructured":"Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI et al (2001). Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39: 32\u201341.","journal-title":"Synapse"},{"key":"BFnpp2016213_CR37","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1124\/mol.115.101394","volume":"89","author":"W Sandtner","year":"2016","unstructured":"Sandtner W, Stockner T, Hasenhuetl PS, Partilla JS, Seddik A, Zhang YW et al (2016). Binding mode selection determines the action of ecstasy homologs at monoamine transporters. Mol Pharmacol 89: 165\u2013175.","journal-title":"Mol Pharmacol"},{"key":"BFnpp2016213_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/bph.12423","volume":"171","author":"CW Schindler","year":"2014","unstructured":"Schindler CW, Thorndike EB, Blough BE, Tella SR, Goldberg SR, Baumann MH (2014). Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats. Br J Pharmacol 171: 83\u201391.","journal-title":"Br J Pharmacol"},{"key":"BFnpp2016213_CR39","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1007\/s00213-015-4057-0","volume":"233","author":"CW Schindler","year":"2016","unstructured":"Schindler CW, Thorndike EB, Goldberg SR, Lehner KR, Cozzi NV, Brandt SD et al (2016). Reinforcing and neurochemical effects of the \u2018bath salts\u2019 constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats. Psychopharmacology 233: 1981\u20131990.","journal-title":"Psychopharmacology"},{"key":"BFnpp2016213_CR40","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","volume":"168","author":"LD Simmler","year":"2013","unstructured":"Simmler LD, Buser TA, Donzelli M, Schramm Y, Dieu LH, Huwyler J et al (2013). Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol 168: 458\u2013470.","journal-title":"Br J Pharmacol"},{"key":"BFnpp2016213_CR41","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.neuropharm.2015.08.030","volume":"99","author":"SA Vandewater","year":"2015","unstructured":"Vandewater SA, Creehan KM, Taffe MA (2015). Intravenous self-administration of entactogen-class stimulants in male rats. Neuropharmacology 99: 538\u2013545.","journal-title":"Neuropharmacology"},{"key":"BFnpp2016213_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s13181-011-0199-6","volume":"8","author":"BJ Warrick","year":"2012","unstructured":"Warrick BJ, Wilson J, Hedge M, Freeman S, Leonard K, Aaron C (2012). Lethal serotonin syndrome after methylone and butylone ingestion. J Med Toxicol 8: 65\u201368.","journal-title":"J Med Toxicol"},{"key":"BFnpp2016213_CR43","unstructured":"Watterson LR, Hood L, Sewalia K, Tomek SE, Yahn S, Johnson CT et al (2012). The reinforcing and rewarding effects of methylone, a synthetic cathinone commonly found in \u2018bath salts\u2019. J Addict Res Ther Suppl 9: pii 002."},{"key":"BFnpp2016213_CR44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0006-8993(95)00774-K","volume":"695","author":"CH Wichems","year":"1995","unstructured":"Wichems CH, Hollingsworth CK, Bennett BA (1995). Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDMA) and other substituted amphetamines in cultured fetal raphe neurons: further evidence for calcium-independent mechanisms of release. Brain Res 695: 10\u201318.","journal-title":"Brain Res"},{"key":"BFnpp2016213_CR45","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/S0006-2952(97)00014-2","volume":"53","author":"D Wu","year":"1997","unstructured":"Wu D, Otton SV, Inaba T, Kalow W, Sellers EM (1997). Interactions of amphetamine analogs with human liver CYP2D6. Biochem Pharmacol 53: 1605\u20131612.","journal-title":"Biochem Pharmacol"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2016213.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2016213","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2016213.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T20:59:03Z","timestamp":1749589143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2016213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,23]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["BFnpp2016213"],"URL":"https:\/\/doi.org\/10.1038\/npp.2016.213","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,23]]},"assertion":[{"value":"19 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}